Jaakko Tuomilehto1, Nicholas Wareham. Show Affiliations » 1. Department of Public Health, University of Helsinki, Helsinki, Finland. jaakko.tuomilehto@ktl.fi
Abstract
Entities: Chemical Disease
Mesh: See more » Blood Glucose/drug effectsDiabetes Mellitus, Type 2/prevention & controlHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/pharmacologyHypoglycemic Agents/therapeutic useRandomized Controlled Trials as TopicRosiglitazoneThiazolidinediones/adverse effectsThiazolidinediones/pharmacologyThiazolidinediones/therapeutic use
Substances: See more » Blood GlucoseHypoglycemic AgentsThiazolidinedionesRosiglitazone
Year: 2006 PMID: 17027710 DOI: 10.1016/S0140-6736(06)69421-X
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321